NO20064864L - Spraytorkede farmasoytiske preparater - Google Patents

Spraytorkede farmasoytiske preparater

Info

Publication number: NO20064864L
Authority: NO; Norway
Prior art keywords: spray; pharmaceutical preparations; dried pharmaceutical; dried; therapy
Prior art date: 2004-03-30

Application number

NO20064864A

Other languages

English (en)

Norwegian (no)

Inventor

Vlasios Andronis

Rennan Pan

Kamlesh Rameshchandra Patel

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-03-30

Filing date

2006-10-25

Publication date

2006-10-25

2006-10-25 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2006-10-25 Publication of NO20064864L publication Critical patent/NO20064864L/no

Links

239000000825 pharmaceutical preparation Substances 0.000 title 1
239000000203 mixture Substances 0.000 abstract 2
BIAVGWDGIJKWRM-FQEVSTJZSA-N 3-hydroxy-2-phenyl-n-[(1s)-1-phenylpropyl]quinoline-4-carboxamide Chemical compound N([C@@H](CC)C=1C=CC=CC=1)C(=O)C(C1=CC=CC=C1N=1)=C(O)C=1C1=CC=CC=C1 BIAVGWDGIJKWRM-FQEVSTJZSA-N 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000002464 receptor antagonist Substances 0.000 abstract 1
229940044551 receptor antagonist Drugs 0.000 abstract 1
229950011332 talnetant Drugs 0.000 abstract 1
238000002560 therapeutic procedure Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20064864A 2004-03-30 2006-10-25 Spraytorkede farmasoytiske preparater NO20064864L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US55757104P	2004-03-30	2004-03-30
PCT/US2005/010350 WO2005097077A2 (en)	2004-03-30	2005-03-28	Spray dried pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
NO20064864L true NO20064864L (no)	2006-10-25

Family

ID=34956393

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20064864A NO20064864L (no)	2004-03-30	2006-10-25	Spraytorkede farmasoytiske preparater

Country Status (26)

Country	Link
US (1)	US20070178151A1 (de)
EP (1)	EP1729734B1 (de)
JP (1)	JP2007530702A (de)
KR (1)	KR20060135000A (de)
CN (1)	CN1933816A (de)
AR (1)	AR048193A1 (de)
AT (1)	ATE387189T1 (de)
AU (1)	AU2005231355B2 (de)
BR (1)	BRPI0508111A (de)
CA (1)	CA2556461A1 (de)
DE (1)	DE602005005033T2 (de)
DK (1)	DK1729734T3 (de)
ES (1)	ES2301003T3 (de)
HR (1)	HRP20080154T3 (de)
IL (1)	IL177606A0 (de)
IS (1)	IS8548A (de)
MA (1)	MA28557B1 (de)
NO (1)	NO20064864L (de)
NZ (1)	NZ549096A (de)
PE (1)	PE20060161A1 (de)
PL (1)	PL1729734T3 (de)
PT (1)	PT1729734E (de)
RU (1)	RU2006138054A (de)
TW (1)	TW200602055A (de)
WO (1)	WO2005097077A2 (de)
ZA (1)	ZA200606670B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0506800D0 (en) *	2005-04-04	2005-05-11	Merck Sharp & Dohme	New uses
JP2009510099A (ja) *	2005-09-30	2009-03-12	スミスクライン・ビーチャム・コーポレイション	医薬組成物
TW200803854A (en) *	2005-09-30	2008-01-16	Smithkline Beecham Corp	Pharmaceutical compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5145684A (en) *	1991-01-25	1992-09-08	Sterling Drug Inc.	Surface modified drug nanoparticles
DE69531458T2 (de) *	1994-05-27	2004-08-05	Glaxosmithkline S.P.A.	Chinolinderivate als tachykinin nk3 rezeptor antagonisten
US6936277B2 (en) *	1995-01-09	2005-08-30	J. Rettenmaier & Soehne Gmbh & Co. Kg	Pharmaceutical excipient having improved compressibility
DE19501269A1 (de) *	1995-01-18	1996-07-25	Henkel Kgaa	Amorphes Alkalisilikat-Compound
US20040013613A1 (en) *	2001-05-18	2004-01-22	Jain Rajeev A	Rapidly disintegrating solid oral dosage form
AU6294501A (en) *	2000-09-20	2002-04-02	Rtp Pharma Inc	Spray drying process and compositions of fenofibrate
US6620438B2 (en) *	2001-03-08	2003-09-16	Boehringer Ingelheim Pharma Kg	Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
MY134211A (en) *	2001-05-18	2007-11-30	Smithkline Beecham Corp	Novel use
JP2005508939A (ja) *	2001-10-12	2005-04-07	エランファーマインターナショナル，リミティド	即時放出および徐放特性を組み合わせて有する組成物

2005
- 2005-03-28 DE DE602005005033T patent/DE602005005033T2/de not_active Expired - Lifetime
- 2005-03-28 RU RU2006138054/15A patent/RU2006138054A/ru not_active Application Discontinuation
- 2005-03-28 PT PT05730200T patent/PT1729734E/pt unknown
- 2005-03-28 JP JP2007506436A patent/JP2007530702A/ja not_active Withdrawn
- 2005-03-28 EP EP05730200A patent/EP1729734B1/de not_active Expired - Lifetime
- 2005-03-28 PL PL05730200T patent/PL1729734T3/pl unknown
- 2005-03-28 AU AU2005231355A patent/AU2005231355B2/en not_active Ceased
- 2005-03-28 AR ARP050101190A patent/AR048193A1/es not_active Application Discontinuation
- 2005-03-28 NZ NZ549096A patent/NZ549096A/en unknown
- 2005-03-28 BR BRPI0508111-4A patent/BRPI0508111A/pt not_active IP Right Cessation
- 2005-03-28 HR HR20080154T patent/HRP20080154T3/xx unknown
- 2005-03-28 TW TW094109502A patent/TW200602055A/zh unknown
- 2005-03-28 ES ES05730200T patent/ES2301003T3/es not_active Expired - Lifetime
- 2005-03-28 US US10/593,653 patent/US20070178151A1/en not_active Abandoned
- 2005-03-28 KR KR1020067019646A patent/KR20060135000A/ko not_active Withdrawn
- 2005-03-28 CA CA002556461A patent/CA2556461A1/en not_active Abandoned
- 2005-03-28 PE PE2005000347A patent/PE20060161A1/es not_active Application Discontinuation
- 2005-03-28 CN CNA2005800096272A patent/CN1933816A/zh active Pending
- 2005-03-28 AT AT05730200T patent/ATE387189T1/de not_active IP Right Cessation
- 2005-03-28 WO PCT/US2005/010350 patent/WO2005097077A2/en not_active Ceased
- 2005-03-28 DK DK05730200T patent/DK1729734T3/da active
2006
- 2006-08-11 ZA ZA200606670A patent/ZA200606670B/xx unknown
- 2006-08-21 IL IL177606A patent/IL177606A0/en unknown
- 2006-10-06 IS IS8548A patent/IS8548A/is unknown
- 2006-10-25 NO NO20064864A patent/NO20064864L/no not_active Application Discontinuation
- 2006-10-30 MA MA29420A patent/MA28557B1/fr unknown

Also Published As

Publication number	Publication date
WO2005097077A3 (en)	2006-04-13
AU2005231355B2 (en)	2008-09-18
BRPI0508111A (pt)	2007-07-17
JP2007530702A (ja)	2007-11-01
DK1729734T3 (da)	2008-06-16
ZA200606670B (en)	2008-01-30
PT1729734E (pt)	2008-05-29
ES2301003T3 (es)	2008-06-16
WO2005097077A2 (en)	2005-10-20
IS8548A (is)	2006-10-06
PE20060161A1 (es)	2006-05-10
CA2556461A1 (en)	2005-10-20
EP1729734A2 (de)	2006-12-13
PL1729734T3 (pl)	2008-09-30
AR048193A1 (es)	2006-04-05
DE602005005033T2 (de)	2009-03-19
CN1933816A (zh)	2007-03-21
HRP20080154T3 (hr)	2008-10-31
TW200602055A (en)	2006-01-16
US20070178151A1 (en)	2007-08-02
DE602005005033D1 (de)	2008-04-10
NZ549096A (en)	2009-05-31
ATE387189T1 (de)	2008-03-15
MA28557B1 (fr)	2007-04-03
HK1099213A1 (en)	2007-08-10
KR20060135000A (ko)	2006-12-28
AU2005231355A1 (en)	2005-10-20
IL177606A0 (en)	2006-12-10
EP1729734B1 (de)	2008-02-27
RU2006138054A (ru)	2008-05-10

Legal Events

Date	Code	Title	Description
2010-11-01	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
ZA202103587B (en)	2025-09-25	Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use as atr kinase inhibitors
ZA202204284B (en)	2024-09-25	Inhibitors of raf kinases
NO20091299L (no)	2009-04-29	Substituerte sulfonamidderivater
TN2009000446A1 (en)	2011-03-31	P70 s6 kinase inhibitors
HUS1600021I1 (hu)	2016-06-28	MEK inhibitorok és módszerek azok felhasználására
NO20060001L (no)	2006-03-02	Nye P2X7-reseptorantagonister og deres anvendelse
PH12019501639B1 (en)	2023-09-08	Jak1 selective inhibitors
NO20081844L (no)	2008-05-29	Terapeutiske forbindelser
EA201201263A1 (ru)	2013-04-30	Фармацевтическая композиция, содержащая этексилат дабигатрана
SE0301372D0 (sv)	2003-05-09	Novel compounds
EP2617431A3 (de)	2013-12-11	Polypeptid-Inhibitoren von HSP27-Kinase und Verwendungen dafür
TW200716646A (en)	2007-05-01	(S)-N-methylnaltrexone
NO20090305L (no)	2009-02-24	Cyklosporin formuleringer
NO20052493D0 (no)	2005-05-24	Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger.
ATE526318T1 (de)	2011-10-15	Farnesoid-x-rezeptor-agonisten
MY144972A (en)	2011-11-30	Novel amide derivative for inhibiting the growth of cancer cells
CR9304A (es)	2008-03-31	Antagonistas del receptor de glucagon, preparaciones y usos terapeuticos
NO20065190L (no)	2007-01-11	Farmasoytiske sammensetninger omfattende en amfifil stivelse
CY1112376T1 (el)	2015-12-09	Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
EA200870545A1 (ru)	2009-12-30	Новые гетероциклические соединения
WO2016065028A8 (en)	2016-06-30	Crystalline forms of 5-chloro-n4-[-2-(dimethylphosphoryl) phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] pyrimidine-2,4-diamine
NO20054762L (no)	2006-01-24	Polymorphs of aripiprazole
MX387785B (es)	2025-03-18	Compuestos heteroarilo y su uso como farmacos terapeuticos.
NO20082130L (no)	2008-06-23	3-Amino-1-arylpropylindoler og aza-substituerte indoler
WO2008004100A9 (en)	2012-04-19	Therapeutic compounds